The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation - PubMed (original) (raw)

L Sanz et al. EMBO J. 1999.

Abstract

The two members of the atypical protein kinase C (aPKC) subfamily of isozymes (zetaPKC and lambda/iotaPKC) are involved in the control of nuclear factor kappaB (NF-kappaB) through IKKbeta activation. Here we show that the previously described aPKC-binding protein, p62, selectively interacts with RIP but not with TRAF2 in vitro and in vivo. p62 bridges the aPKCs to RIP, whereas the aPKCs link IKKbeta to p62. In this way, a signaling cascade of interactions is established from the TNF-R1 involving TRADD/RIP/p62/aPKCs/IKKbeta. These observations define a novel pathway for the activation of NF-kappaB involving the aPKCs and p62. Consistent with this model, the expression of a dominant-negative mutant lambda/iotaPKC impairs RIP-stimulated NF-kappaB activation. In addition, the expression of either an N-terminal aPKC-binding domain of p62, or its C-terminal RIP-binding region are sufficient to block NF-kappaB activation. Furthermore, transfection of an antisense construct of p62 severely abrogates NF-kappaB activation. Together, these results demonstrate that the interaction of p62 with RIP serves to link the atypical PKCs to the activation of NF-kappaB by the TNFalpha signaling pathway.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3537-42 - PubMed
    1. J Cell Biol. 1999 Feb 8;144(3):403-11 - PubMed
    1. Mol Cell Biol. 1998 May;18(5):3069-80 - PubMed
    1. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9319-24 - PubMed
    1. J Cell Biol. 1998 Oct 5;143(1):95-106 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources